FindMyKOL
Clinical trialNCT04806893UnknownPhase 3Interventional

Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction

SponsorLIB Therapeutics LLCEnrollment900Cardiovascular DiseasesCardiovascular Risk FactorCardiovascular StrokeHypercholesterolemia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is to assess LDL-C reductions at Week 52 with monthly (Q4W \[≤31 days\]) dosing of LIB003 (lerodalcibep) 300 mg administered subcutaneously (SC) compared to placebo in patients with CVD, or at high risk for CVD, on a stable diet and oral LDL-C lowering drug therapy
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

India
  • G.B. Pant Institute of Postgraduate Medical Education & Research

    New Delhi, India

Israel
  • Department of Medicine, Hadassah University Hospital

    Jerusalem, Israel

  • Rabin Medical Center, Beilinson Hospital,

    Petah Tikva, Israel

United States
  • Metabolic & Atherosclerosis Research Center (marc)

    Cincinnati, Ohio, United States

  • Sterling Research Group

    Cincinnati, Ohio, United States

  • the Lindner Research Center

    Cincinnati, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Lerodalcibep
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Apr 2021
Primary completion
15 Nov 2023
Completion
28 Feb 2024
Last update posted
11 Dec 2023
Registered enrollment
900
Registry id
NCT04806893
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.